GSK Pharma board approves sale of Vemgal plant to Hetero Labs The board of directors at its meeting held on Tuesday, approved the sale of the company's business undertaking i.e., manufacturing ...
British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...
British drugmaker GSK said on Wednesday its experimental herpes simplex virus (HSV) vaccine candidate failed to meet the main ...
Hundreds of workers at pharmaceutical giant ... formerly known as GlaxoSmithKline, include engineers, process technicians, laboratory analysts, warehouse workers and fire officers.
As part of a new series looking at how pharma has responded to the pandemic, Neale Belson, SVP UK & Ireland and general manager for the UK at GSK, tells us that it is “absolutely critical” to ...
GSK lifted its sales and earnings projections for the year, after a strong performance by its HIV and cancer drugs drove ...
GSK signs AllTrials data transparency campaign In an unusual development, one day after the Pharmaceutical Research &, Manufacturers of America trade group in the US harshly criticized a call ...
We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Short Sellers. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the ...
GlaxoSmithKline Pharmaceuticals Ltd on Friday reported a 37.87 per cent rise in consolidated net profit at Rs 182.33 crore in the first quarter ended June 30, 2024. The company had posted a ...
Motilal Oswal recommended Neutral rating on GSK Pharma with a target price of Rs 2620 in its research report dated August 05, 2024. GSK Pharma reported better than expected PAT on lower raw ...
GSK plc (NYSE:GSK) Short Interest as % of Shares Outstanding: 0.60% Number of Hedge Fund Investors In Q2 2024: 36 GSK plc (NYSE:GSK) is a British pharmaceutical giant headquartered in Brentford ...
Motilal Oswal recommended Neutral rating on GSK Pharma with a target price of Rs 2620 in its research report dated August 05, 2024. GSK Pharma reported better than expected PAT on lower raw ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback